Travel support 2019 France, Oct 1-2
Reference number | |
Coordinator | ONCORENA AB |
Funding from Vinnova | SEK 10 500 |
Project duration | September 2019 - October 2019 |
Status | Completed |
Important results from the project
The meeting in Paris fully accomplished the objectives to meet and discuss investments in Oncorena with French investment companies
Expected long term effects
The meeting in Paris fully accomplished the objectives to meet and discuss investments in Oncorena with French investment companies. There will be follow up meetings to further discuss investments.
Approach and implementation
The meeting with Sweden Bio and French lifescience investors at the Swedish Embassy in Paris and BPI France resulted in a series of 1:1 meetings with French lifescience investment executives to discuss raising of Series A money for 2020.